4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile
C33H27F2N3O3 — CID 170067242
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile
4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile (PubChem CID 170067242) has the molecular formula C33H27F2N3O3 and a molecular weight of 551.59 g/mol. Its IUPAC name is 4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile.
Molecular Properties
| Compound Name | 4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile |
|---|---|
| PubChem CID | 170067242 |
| Molecular Formula | C33H27F2N3O3 |
| Molecular Weight | 551.59 g/mol |
| Exact Mass | 551.20 |
| IUPAC Name | 4-[[2-[4-[[6-acetyl-1-(2-methoxyethyl)benzimidazol-2-yl]methyl]-3-fluorophenyl]phenoxy]methyl]-3-fluorobenzonitrile |
| SMILES | COCCn1c(Cc2ccc(-c3ccccc3OCc3ccc(C#N)cc3F)cc2F)nc2ccc(C(C)=O)cc21 |
| InChI | InChI=1S/C33H27F2N3O3/c1-21(39)23-11-12-30-31(17-23)38(13-14-40-2)33(37-30)18-25-10-9-24(16-29(25)35)27-5-3-4-6-32(27)41-20-26-8-7-22(19-36)15-28(26)34/h3-12,15-17H,13-14,18,20H2,1-2H3 |
| InChIKey | XAFHZIAKNKIUDT-UHFFFAOYSA-N |
| XLogP | 6.87 |
| TPSA | 77.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 551.59 |
| LogP ≤ 5 | 6.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170067242 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.